{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:14:49Z","timestamp":1773162889958,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.carrev.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T20:00:28Z","timestamp":1454961628000},"page":"399-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A single center experience of Zilver PTX for femoro-popliteal lesions"],"prefix":"10.1016","volume":"17","author":[{"given":"Won Yu","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Campia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain J.","family":"Didier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarkis","family":"Kiramijyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Koifman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita I.","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Lipinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin C.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo O.","family":"Escarcega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson L.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2016.02.004_bb0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2016.02.004_bb0010","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2016.02.004_bb0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.addr.2006.01.023","article-title":"The Taxus drug-eluting stent: a new paradigm in controlled drug delivery","volume":"58","author":"Kamath","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.carrev.2016.02.004_bb0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.carrev.2016.02.004_bb0025","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.02.004_bb0030","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","author":"Gray","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.02.004_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.02.004_bb0045","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.02.004_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","article-title":"Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry","volume":"5","author":"Micari","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.02.004_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcin.2013.01.128","article-title":"2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry","volume":"6","author":"Micari","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.02.004_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.02.004_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.02.004_bb0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1583\/11-3560.1","volume":"18","author":"Dake","year":"2011","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.carrev.2016.02.004_bb0075","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.02.004_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jvir.2010.12.027","article-title":"Polymer-free paclitaxel-coated Zilver PTX Stents--evaluation of pharmacokinetics and comparative safety in porcine arteries","volume":"22","author":"Dake","year":"2011","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"10.1016\/j.carrev.2016.02.004_bb0085","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","article-title":"Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results","volume":"106","author":"Duda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.02.004_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.RVI.0000151260.74519.CA","article-title":"Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial","volume":"16","author":"Duda","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2016.02.004_bb0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jvs.2011.01.047","article-title":"First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease","volume":"54","author":"Lammer","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2016.02.004_bb0100","first-page":"149","article-title":"Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent","volume":"7","author":"Litsky","year":"2014","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.carrev.2016.02.004_bb0105","first-page":"115","article-title":"Strickler S; Zilver PTX Single-Arm Study Investigators. The Zilver\u00ae PTX\u00ae Single Arm Study: 12-month results from the TASC C\/D lesion subgroup","volume":"54","author":"Bosiers","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.carrev.2016.02.004_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.carrev.2016.02.004_bb0115","first-page":"229","article-title":"Effectiveness of Zilver PTX eluting stent in TASC C\/D lesions and restenosis","volume":"55","author":"Leopardi","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.carrev.2016.02.004_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcin.2012.12.118","article-title":"Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents","volume":"6","author":"Zeller","year":"2013","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916300148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916300148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:11:07Z","timestamp":1761559867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838916300148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1553838916300148"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2016.02.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single center experience of Zilver PTX for femoro-popliteal lesions","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}